Mail

Australia markets open in 37 minutes

ALL ORDS
7,386.70
+116.90(+1.61%)
AUD/USD
0.6556
-0.0002(-0.02%)
ASX 200
7,178.40
+116.80(+1.65%)
OIL
69.24
-3.08(-4.26%)
GOLD
2,043.40
+7.10(+0.35%)
Bitcoin AUD
67,011.00
-488.05(-0.72%)

FEELING THE PINCH?

Beat the cost-of-living squeeze with our pro tips and helpful hacks - sign up now

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

1.4400

-0.0100

(-0.69%)

At close: 04:00PM EST

1.4800

+0.04

(+2.78%)

After hours:

04:43PM EST

Currency in USD

Valuation measures⁴

Market cap (intra-day)	217.61M
Enterprise value	320.19M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	1.54
Price/book (mrq)	12.60
Enterprise value/revenue	2.61
Enterprise value/EBITDA	-2.61

Trading information

Stock price history

Beta (5Y monthly)	1.51
52-week change ³	-42.91%
S&P500 52-week change ³	16.10%
52-week high ³	3.4100
52-week low ³	0.5000
50-day moving average ³	0.9008
200-day moving average ³	1.5230

Share statistics

Avg vol (3-month) ³	2.95M
Avg vol (10-day) ³	3.26M
Shares outstanding ⁵	150.07M
Implied shares outstanding ⁶	155.25M
Float ⁸	113.86M
% held by insiders ¹	0.78%
% held by institutions ¹	92.05%
Shares short (14 Nov 2023) ⁴	17.59M
Short ratio (14 Nov 2023) ⁴	5.85
Short % of float (14 Nov 2023) ⁴	13.50%
Short % of shares outstanding (14 Nov 2023) ⁴	11.72%
Shares short (prior month 12 Oct 2023) ⁴	19.36M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	1:20
Last split date ³	12 Jan 2014

Financial highlights

Fiscal year

Fiscal year ends	30 Dec 2022
Most-recent quarter (mrq)	29 Sept 2023

Profitability

Profit margin	-97.45%
Operating margin (ttm)	-66.26%

Management effectiveness

Return on assets (ttm)	-24.51%
Return on equity (ttm)	N/A

Income statement

Revenue (ttm)	122.84M
Revenue per share (ttm)	0.94
Quarterly revenue growth (yoy)	18.40%
Gross profit (ttm)	-50.51M
EBITDA	-95.28M
Net income avi to common (ttm)	-119.7M
Diluted EPS (ttm)	-0.8800
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	77.41M
Total cash per share (mrq)	0.52
Total debt (mrq)	180M
Total debt/equity (mrq)	N/A
Current ratio (mrq)	2.43
Book value per share (mrq)	-0.20

Cash flow statement

Operating cash flow (ttm)	-98.78M
Levered free cash flow (ttm)	-51.44M